C12Y 204/99006
N-acetyllactosaminide alpha-2,3-sialyltransferase
Official title: N-Acetyllactosaminide alpha-2,3-sialyltransferase (2.4.99.6)
C12Y204/99006 (N-acetyllactosaminide alpha-2,3-sialyltransferase) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 5
- Assignees
- 3
- Inventors
- 17
- Latest grant
- 27 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 2 |
By publication year.
Recent patents
- Engineered and Fully-Functional Customized Glycoproteins29 Aug 2024US 2024/0287568 A1Limmatech Biologics AG
- Modular glycan production with immobilized bionanocatalysts25 Apr 2024US 2024/0132927 A1ZYMtronix Catalytic Systems, Inc.
- Synthesis of c-glycosides of interest5 Oct 2023US 2023/0313248 A1
- Engineered and fully-functional customized glycoproteins28 Oct 2021US 2021/0332403 A1Limmatech Biologics AG
- Compositions and Methods for Reducing Skin Pigmentation21 Jan 2016US 2016/0015617 A1Yale University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.